NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Clarkes granted appeal on interviews
Law & Regulation

Clarkes granted appeal on interviews

Du Val founders get leave to appeal interview order with receivers PwC.

Garth Bray 27 May 2025
Fonterra divestment ‘not about waving the white flag’
Primary Sector

Fonterra divestment ‘not about waving the white flag’

Fonterra seeks strong support for divestment, but Hurrell denies white flags on brands.

My Net Worth: Kevin Bryant, NZ Veterinary Association CEO
Editor's Picks

My Net Worth: Kevin Bryant, NZ Veterinary Association CEO

"My best business advice is to be true to yourself and not compromise your values."